The Bank of New York (Nominees) Limited |
87,763,271 |
£62,311,922 |
Harwood Capital LLP |
70,315,021 |
£49,923,665 |
AstraZeneca PLC |
66,093,108 |
£46,926,107 |
Nortrust Nominees Limited |
58,832,384 |
£41,770,993 |
State Street Nominees Limited |
51,334,357 |
£36,447,394 |
Imperial Innovations Businesses LLP |
47,355,417 |
£33,622,346 |
Rathbones Investment Management Ltd |
43,924,103 |
£31,186,113 |
Chase (GA Group) Nominees Limited |
36,606,654 |
£25,990,724 |
Oryx International Growth Fund Limited |
30,000,000 |
£21,300,000 |
PH Nominees Limited |
28,324,296 |
£20,110,250 |
Chase Nominees Limited |
23,185,617 |
£16,461,788 |
Richard Griffiths |
22,395,510 |
£15,900,812 |
Charles Stanley Group Plc |
21,045,925 |
£14,942,607 |
Lombard Odier Asset Management (Europe) Limited |
18,133,419 |
£12,874,728 |
Neptune Investment Management Limited |
17,909,985 |
£12,716,089 |
Invesco Limited |
15,660,000 |
£11,118,600 |
Danske Bank A/S |
13,653,594 |
£9,694,052 |
CIP Merchant Capital Limited |
12,800,000 |
£9,088,000 |
Odey Asset Management LLP |
12,688,236 |
£9,008,648 |
Lansdowne Partners International Limited |
7,893,712 |
£5,604,536 |